methylprednisolone + prednisone + cyclosporine A

A combination immunosuppressive therapy consisting of two corticosteroids (methylprednisolone and prednisone) and cyclosporine A. This regimen provides potent immunosuppression through complementary mechanisms of action. The corticosteroids deliver potent anti-inflammatory effects while cyclosporine A inhibits T-cell function through calcineurin inhibition[1][2]. When used together, these medications can achieve more rapid clinical remission compared to corticosteroid monotherapy in certain conditions. For example, in pemphigus vulgaris, the combination of cyclosporine with prednisone resulted in faster cessation of new blister formation (11.1 days vs 20.5 days) and shorter hospital stays (32.6 days vs 50.7 days) compared to prednisone alone[1]. This combination therapy has been studied in several conditions: - **Pemphigus vulgaris**: The combination showed faster clinical remission and shorter hospital stays compared to prednisone monotherapy[1]. - **Minimal change nephrotic syndrome (MCNS)**: Cyclosporine combined with methylprednisolone pulse therapy and oral prednisolone shortened hospital stays and decreased the total amount of prednisolone needed without severe adverse effects[2]. - **Organ transplantation**: Used to prevent organ rejection, though careful monitoring is required due to potential interactions[6].